NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
Sidney Kimmel Comprehensive Cancer Center · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · +44 more institutions
Abstract
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.
Citation impact
- FWCI
- 115.16
- Percentile
- 100%
- References
- 29
Authors
43- DSDavid S. EttingerCorresponding
Sidney Kimmel Comprehensive Cancer Center
- DEDouglas E. Wood
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Fred Hutch Cancer Center
- DLDara L. Aisner
University of Colorado Cancer Center, University of Colorado Denver
- WAWallace Akerley
University of Utah, Huntsman Cancer Institute
- JRJessica R. Bauman
Fox Chase Cancer Center
Topics & keywords
- Medicine
- Lung cancer
- Oncology
- Neoadjuvant therapy
- Perioperative
- Internal medicine
- Systemic therapy
- Adjuvant
- Good health and well-being